Biogen Idec Inc (NASDAQ:BIIB)
| 226.85 Data as of May 17 |  -1.14 / -0.50%Today’s Change | 126.39 Today|||52-Week Range 231.99 | +54.98% Year-to-Date |
Latest BIIB News | Press Releases
| AGN, LLY, BIIB, CELG And AMGN, Pushing Health Care Sector Downward May 16 / TheStreet.com | Elan seeks to weaken hostile bid with $1bn Theravance deal May 13 / FT.com |
| Biogen Idec Inc (BIIB): Today's Featured Health Care Laggard May 15 / TheStreet.com | Narrower-than-Expected Loss at Seattle Genetics - Analyst Blog May 08 / Zacks.com |
| Cramer's 'Mad Money' Recap: Stick With What Works May 14 / TheStreet.com | Bayer Discontinues Hemophilia Study - Analyst Blog May 06 / Zacks.com |
| Isis Gets $3.5M Milestone Payment - Analyst Blog May 14 / Zacks.com | Acorda Incurs Loss, Maintains Guidance - Analyst Blog May 06 / Zacks.com |
| Biogen Idec Stock Hits New 52-Week High (BIIB) May 14 / TheStreet.com |
Today’s Trading
| Previous close | 227.99 |
| Today’s open | 228.36 |
| Day’s range | 224.60 - 228.86 |
| Volume | 1,243,879 |
| Average volume (3 months) | 1,371,653 |
| Market cap | $53.8B |
| Dividend yield | -- |
Data as of 4:00pm ET, 05/17/2013
Growth & Valuation
| Earnings growth (last year) | +14.29% |
| Earnings growth (this year) | +23.19% |
| Earnings growth (next 5 years) | +17.80% |
| Revenue growth (last year) | +7.78% |
| P/E ratio | 36.0 |
| Price/Sales | 6.35 |
| Price/Book | 7.71 |
Competitors
| Today’s change | Today’s % change | |
|---|---|---|
| BAXBaxter International... | +1.09 | +1.52% |
| AMGNAmgen Inc | +0.66 | +0.63% |
| GILDGilead Sciences Inc | +1.34 | +2.44% |
| LIFELife Technologies Co... | +0.05 | +0.07% |
Data as of 4:00pm ET, 05/17/2013
Financials
| Next reporting date | July 23, 2013 |
| EPS forecast (this quarter) | $1.91 |
| Annual revenue (last year) | $5.5B |
| Annual profit (last year) | $1.4B |
| Net profit margin | 25.18% |
Profile
Sector Health Technology |
Industry Biotechnology |
Chief Executive Officer & Director George A. Scangos, PhD |
Chief Financial Officer & Executive Vice President Paul J. Clancy, MBA |
Corporate headquarters Weston, Massachusetts |
Forecasts
